Waddell & Associates’s Zoetis ZTS Stock Holding History

Waddell & Associates’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,030	Closed	-$297K	–	414
2025 Q3	$297K	Buy	+2,030	New	+$307K	0.03%	215

Other funds holding ZTS

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Waddell & Associates's ZTS Position: Q4 2025 in Review

Waddell & Associates sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 2,030 shares — an estimated $297K sold.

Waddell & Associates first reported a position in ZTS in Q3 2025 and held it in 1 quarter. The position peaked at $297K in Q3 2025. 1,679 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

Waddell & Associates reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
Waddell & Associates sold 2,030 Zoetis shares in Q4 2025, an estimated $297K.
Waddell & Associates first reported a position in Zoetis in Q3 2025 and held it in 1 quarter.
Waddell & Associates's Zoetis position peaked at $297K in Q3 2025.
1,679 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Waddell & Associates's 13F filing for Q4 2025, filed 11 Feb 2026.